These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11840659)

  • 21. Argatroban for elective percutaneous coronary intervention: the ARG-E04 multi-center study.
    Rössig L; Genth-Zotz S; Rau M; Heyndrickx GR; Schneider T; Gulba DC; Desaga M; Buerke M; Harder S; Zeiher AM;
    Int J Cardiol; 2011 Apr; 148(2):214-9. PubMed ID: 20226548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.
    Yarbrough PM; Varedi A; Walker A; Rondina MT
    Ann Pharmacother; 2012 Nov; 46(11):e30. PubMed ID: 23073302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost-effectiveness of argatroban treatment in heparin-induced thrombocytopenia: the effect of early versus delayed treatment.
    Arnold RJ; Kim R; Tang B
    Cardiol Rev; 2006; 14(1):7-13. PubMed ID: 16371760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Heparin-induced thrombocytopenia after on-pump coronary artery bypass grafting].
    Kigawa I; Okamura Y; Fukuda S; Miyairi T
    Kyobu Geka; 2010 Jun; 63(6):442-5. PubMed ID: 20533732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE; Hursting MJ
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of argatroban for extracorporeal life support in patients with nonheparin-induced thrombocytopenia: Analysis of 10 consecutive patients.
    Kim YS; Lee H; Yang JH; Sung K; Suh GY; Chung CR; Yang JH; Cho YH
    Medicine (Baltimore); 2018 Nov; 97(47):e13235. PubMed ID: 30461625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of argatroban during cardiopulmonary bypass for atrial septal defect with heparin induced thrombocytopenia after introduction of dialysis].
    Ishida H; Yamazaki T
    Kyobu Geka; 2009 Feb; 62(2):122-4. PubMed ID: 19202931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
    Matthai WH
    Semin Thromb Hemost; 1999; 25 Suppl 1():57-60. PubMed ID: 10357153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation.
    Nanda MM; Kauflin MJ; Jain PG; Yannetta JC
    Ann Pharmacother; 2011 Mar; 45(3):e16. PubMed ID: 21386022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Argatroban for anticoagulation in pediatric patients with heparin-induced thrombocytopenia requiring extracorporeal life support.
    Potter KE; Raj A; Sullivan JE
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):265-8. PubMed ID: 17414571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful use of Argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient.
    Edwards JT; Hamby JK; Worrall NK
    Ann Thorac Surg; 2003 May; 75(5):1622-4. PubMed ID: 12735590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of argatroban, direct thrombin inhibitor, in heparin-intolerant patients requiring extracorporeal circulation.
    Matsuo T; Koide M; Kario K
    Artif Organs; 1997 Sep; 21(9):1035-8. PubMed ID: 9288875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.
    Hellwig TR; Peitz GJ; Gulseth MP
    Am J Health Syst Pharm; 2012 Mar; 69(6):490-5. PubMed ID: 22382479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
    Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
    Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
    J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of heparin-induced thrombocytopenia associated with unexpected excessive argatroban anticoagulation after abdominal aortic aneurysm resection].
    Ichikawa M; Oue M; Okamoto A; Morishita H; Minatoya K; Ogino H; Miyata S; Imanaka H
    Masui; 2006 Feb; 55(2):188-92. PubMed ID: 16491897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of argatroban.
    Jeske WP; Fareed J; Hoppensteadt DA; Lewis B; Walenga JM
    Expert Rev Hematol; 2010 Oct; 3(5):527-39. PubMed ID: 21083469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Argatroban: a direct thrombin inhibitor for heparin-induced thrombocytopenia and other clinical applications.
    Chen JL
    Heart Dis; 2001; 3(3):189-98. PubMed ID: 11975790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of pulmonary embolism with argatroban and ultrasound-assisted catheter-directed thrombolysis with alteplase in a patient with heparin-induced thrombocytopenia.
    Bethea BT; Elliot JW; Richardson JB; Ahmed MI
    Am J Health Syst Pharm; 2017 Aug; 74(15):1153-1157. PubMed ID: 28743779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.